PepTalk 2017 | From Protein Science R&D to Therapeutics: Expert Insights (Part 1)

Dr. Thomas Laue of University of New Hampshire, Bjørn Voldborg of Technical University of Denmark, and Dr. Andrew Fosberry of GlaxoSmithKline speak to Cambridge Healthtech Institute. They are part of “It’s a Wrap”, the closing plenary panel discussion representing various R&D stages at PepTalk: The Protein Science Week, January 9-13 in San Diego, California. They each consider this question: What do you see as the next, most promising innovation in your field?